Key result
A 12-month physician-supervised exercise training program for patients with heart failure was feasible and safe, yielding a subtle increase in exercise capacity% predicted from 66.5% to 67%.
Why the study?
Exercise training in heart failure is recommended but not routinely offered due to logistic and safety reasons; this study aimed to evaluate the feasibility and safety of establishing a dedicated HF training group in Germany.
Does a supervised heart failure exercise program improve peakVO2 and other surrogate markers in patients with symptomatic heart failure and LVEF ≤ 45%?
Cohort (n=12)
Open-label
No
Does a supervised heart failure exercise program improve peakVO2 and other surrogate markers in patients with symptomatic heart failure and LVEF ≤ 45%?
A supervised, dedicated exercise training group for patients with heart failure is feasible, safe, and associated with improvements in quality of life, LVEF, and NT-proBNP over 12 months.
Answers are grounded in this paper and cite their sources.
Supports the initial feasibility of dedicated exercise groups for symptomatic HF; leaves open whether broader implementation improves.
Background Exercise training in heart failure (HF) is recommended but not routinely offered, because of logistic and safety-related reasons. In 2020, the German Society for Prevention&Rehabilitation and the German Society for Cardiology requested establishing dedicated “HF training groups.” Here, we aimed to implement and evaluate the feasibility and safety of one of the first HF training groups in Germany. Methods Twelve patients (three women) with symptomatic HF (NYHA class II/III) and an ejection fraction ≤ 45% participated and were offered weekly, physician-supervised exercise training for 1 year. Patients received a wrist-worn pedometer (M430 Polar) and underwent the following assessments at baseline and after 4, 8 and 12 months: cardiopulmonary exercise test, 6-min walk test, echocardiography (blinded reading), and quality of life assessment (Kansas City Cardiomyopathy Questionnaire, KCCQ). Results All patients (median age [quartiles] 64 [49; 64] years) completed the study and participated in 76% of the offered 36 training sessions. The pedometer was worn ≥ 1000 min per day over 86% of the time. No cardiovascular events occurred during training. Across 12 months, NT-proBNP dropped from 986 pg/ml [455; 1937] to 483 pg/ml [247; 2322], and LVEF increased from 36% [29;41] to 41% [32;46]%, (p for trend = 0.01). We observed no changes in exercise capacity except for a subtle increase in peak VO2% predicted, from 66.5 [49; 77] to 67 [52; 78]; p for trend = 0.03. The physical function and social limitation domains of the KCCQ improved from 60 [54; 82] to 71 [58; 95, and from 63 [39; 83] to 78 [64; 92]; p for trend = 0.04 and = 0.01, respectively. Positive trends were further seen for the clinical and overall summary scores. Conclusion This pilot study showed that the implementation of a supervised HF-exercise program is feasible, safe, and has the potential to improve both quality of life and surrogate markers of HF severity. This first exercise experiment should facilitate the design of risk-adopted training programs for patients with HF.
No takes yet. Share an insight, caveat, or question.
Güder et al. (2021) conducted a cohort in Heart failure (n=12). Physician-supervised exercise training was evaluated on 12-month change in peak VO2 at cardiopulmonary exercise testing (p=0.03). A 12-month physician-supervised exercise training program for patients with heart failure was feasible and safe, yielding a subtle increase in exercise capacity% predicted from 66.5% to 67%.
Synapse has enriched 10 related papers. Consider them for comparative context: